Creo Medical (GB:CREO) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Creo Medical’s CFO Richard Rees executed a ‘Bed and ISA’ transaction, selling and repurchasing over 174,000 company shares, while his associate Rachel Rees acquired the remaining shares. This strategic move reflects internal confidence in the medical device firm’s focus on advanced energy solutions for surgical endoscopy.
For further insights into GB:CREO stock, check out TipRanks’ Stock Analysis page.
